Cogent Biosciences (COGT) EBITDA Margin Growth (1y) (2018 - 2020)
Powered by 
Analysis
Cogent Biosciences (COGT) EBITDA Margin Growth (1y) (2018 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Cogent Biosciences | 5.94 Bn | 5.94 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -1.72 Mn |
| Jun 30, 2020 | -106,617.00 |
| Mar 31, 2020 | 30,051.00 |
| Dec 31, 2019 | 25,129.00 |
| Sep 30, 2019 | -66,233.00 |
| Jun 30, 2019 | 23,065.00 |
| Mar 31, 2019 | -7,316.00 |
| Dec 31, 2018 | 8,743.00 |
| Sep 30, 2018 | -21,008.00 |
| Jun 30, 2018 | -27,638.00 |
| Mar 31, 2018 | 1,750.00 |